Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
Dodel RC, Kirchner A, Koehne-Volland R, Künig G, Ceballos-Baumann A, Naumann M, Brashear A, Richter HP, Szucs TD, Oertel WH.
Dodel RC, et al. Among authors: kunig g.
Pharmacoeconomics. 1997 Dec;12(6):695-706. doi: 10.2165/00019053-199712060-00009.
Pharmacoeconomics. 1997.
PMID: 10175981